semaglutide deaths Weight loss drug Wegovy reduced risk of COVID-19 deaths: Study UK Warns of Severe Pancreatitis,

The rise of GLP-1 receptor agonists (GLP-1RA) therapies has created unprecedented demand for high-volume injectable manufacturing

GLP-1-Related Cancellations Cost ASCs Thousands: How Dialog Healths Texting Platform Helps Keep Patients Safe and Cases on Track Brandon Daniell Nov 24, 2025 5 min read Updated: Dec 10, 2025 Key Takeaways on GLP-1-Related Cancellations Costing ASCs Thousands GLP-1 medications cause delayed gastric emptying, creating aspiration risks that force same-day cancellations costing ASCs $500-$3,000 per empty OR hour Traditional pre-op communication fails because phone calls reach voicemail, printed instructions get lost, and patients don't connect their "diabetes medication" to surgical requirements Dialog Health's 10-day automated text protocol screens patients early, with 71% responding in a median of just 13 minutes One facility's case study shows 2,184 cancellations prevented over 18 months after identifying 12% of patients as GLP-1 users who needed specific stop-date instructions Simple screening texts like "Are you taking Ozempic, Wegovy, or another GLP-1?" followed by clear timing instructions protect revenue, OAS CAHPS scores , and patient trust simultaneously The Hidden Risk in Your OR Schedule You've probably seen it happen

When used under medical supervision, peptides like CJC-1295 provide a non-invasive approach to enhancing vitality, allowing people to stay physically active and youthful in their appearance

Co-morbid diabetes in patients with Crohns disease predicts a greater need for surgical intervention